Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01536340 · ClinicalTrials.gov registry record
Identifying Adverse Events After Discharge From a Community Hospital
A clinical trial, sponsored by Florida State University.
- Completed
- Registry status
- 684
- Enrollment target
NCT01536340: Completed study, sponsored by Florida State University.
NCT01536340 is a clinical trial that has completed, run by Florida State University. The registered enrollment target is 684 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01536340 has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- 684 participants
- Enrollment target
Study Summary
The purpose of this study is to: -Determine the incidence of adverse events, preventable adverse events, and ameliorable adverse events, and the timeliness of post-discharge ambulatory appointments, affecting urban and rural patients approximately 3-4 weeks after discharge from a hospitalist-run medical service of a large community hospital to home. H1: The incidence of post-discharge adverse events will be higher in rural patients compared with urban patients discharged from a hospitalist-run medical service of a large community hospital. -Identify and classify the types of post-discharge adverse events (e.g., adverse drug events, procedure-related events, hospital acquired (nosocomial) infections, falls, and other) affecting urban and rural patients approximately 3-4 weeks after discharge from a hospitalist-run medical service of a large community hospital to home. H2: All patients will be at higher risk for adverse drug events than other types of adverse events. -Examine the relationships between the population at risk, characteristics of the health care delivery system, and the utilization of post-discharge health services, and how these relationships help us understand the incidence of post-discharge adverse events. H3: Several factors will be independently associated with the incidence of post-discharge adverse events in rural and urban patients, including patient comorbidity, severity of acute illness, presence of a primary care physician prior to hospitalization, and a scheduled timely post-discharge ambulatory follow-up appointment.
Primary Outcome
Patients are contacted 3-6 weeks after discharge for a phone interview. They are questioned about potential adverse events following their discharge from the hospital. Interviewers/nurses conduct a review of systems to determine if the patient experienced an adverse event. Potential cases are flagged on the basis of unexpected health care utilization, new/exacerbated symptoms and/or abnormal lab test results. Cases are reviewed by two independent physician reviewers to determine whether the adve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 684 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-10 |
What the finished NCT01536340 record still lists
NCT01536340 is an observational study that tracks outcomes without assigning an intervention. The registered 684 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01536340 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01536340 about?
NCT01536340 is a clinical study titled "Identifying Adverse Events After Discharge From a Community Hospital". The purpose of this study is to: -Determine the incidence of adverse events, preventable adverse events, and ameliorable adverse events, and the timeliness of post-discharge ambulatory appointments, affecting urban and rural patients approximately 3-4 weeks after discharge from a hospitalist-run me...
What is the current status of trial NCT01536340?
This trial is currently completed. The enrollment target is 684 participants. The study started on 2011-09. Estimated completion is 2014-10.
Who is sponsoring clinical trial NCT01536340?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06795087 · 684 participants
Discharge Medication Use Post-Operatively in GU Cancer Patients
- NCT05099770 · 685 participants · Phase 3
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
- NCT05880199 · 685 participants
BSGM to Evaluate Patients With GI Symptoms
- NCT04333537 · 686 participants · Phase 2
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia